As shown in Fig. 7, the CD133+ glioblastoma cell induced-tumor tissue expressed significantly higher levels of Oct4, Sox2, PCNA, EGFR, Ang2, MMP2 and MMP9 proteins compared with the CD133− glioblastoma cell induced-tumor tissue (P<0.05). This evidence concerns the gene SOX2 and glioblastoma.